RISING PHARMA HOLDINGS, INC. Escitalopram Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Escitalopram from India and how much does RISING PHARMA HOLDINGS, INC. import?

India exports Escitalopram to 628 buyers globally worth $33.3M. RISING PHARMA HOLDINGS, INC. imports $3.5M (1.6% market share) with 194 shipments from UNITED STATES.

Q: What is the average order value for RISING PHARMA HOLDINGS, INC.'s Escitalopram imports?

RISING PHARMA HOLDINGS, INC.'s average Escitalopram order value is $18.2K per consignment, based on 194 shipments totaling $3.5M.

Q: Who supplies Escitalopram to RISING PHARMA HOLDINGS, INC.?

RISING PHARMA HOLDINGS, INC. sources Escitalopram from 2 verified suppliers: GRAVITI PHARMACEUTICALS PRIVATE LIMITED ($3.5M, 98.2%), AUROBINDO PHARMA LIMITED ($63.1K, 1.8%). Based on 194 customs records.

Q: How does RISING PHARMA HOLDINGS, INC. compare to other Escitalopram importers?

RISING PHARMA HOLDINGS, INC. ranks #7 among 628 Escitalopram importers from India with 1.6% market share and 194 shipments.

Q: Who are the top Escitalopram importers from India?

Top Escitalopram importers: TORRENT PHARMA INC ($4.2M), LEK S.A. ($4.1M), CIPLA MAROC ($3.5M), RISING PHARMA HOLDINGS, INC. ($3.1M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($2.9M).

Suresh Sormare

Escitalopram

India Pharmaceutical Trade Intelligence

$196.7M231 Suppliers95 CountriesHS 30049099

ExportsIndia → MOROCCO40.9%India → UNITED STATES23.6%

ImportsCANADA → India$5.3M UNITED STATES → India$18.4K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

RISING PHARMA HOLDINGS, INC. — Escitalopram Importer #7 | $3.5M Trade Value | TransData Nexus | TransData Nexus

RISING PHARMA HOLDINGS, INC. — Escitalopram Importer Profile

Pharmaceutical Importer · #7 buyer for Escitalopram · $3.5M import value · 194 shipments · UNITED STATES · DGFT Verified

RISING PHARMA HOLDINGS, INC. is the #7 importer of Escitalopram from India with $3.5M in import value and 194 verified shipments. RISING PHARMA HOLDINGS, INC. holds a 1.6% market share in Escitalopram imports based in UNITED STATES. The company sources from 2 verified suppliers across 126 formulations shipped to 1 country. Overall, RISING PHARMA HOLDINGS, INC. imports 18 pharmaceutical products worth $87.0M across 11 therapeutic categories.

RISING PHARMA HOLDINGS, INC. — Escitalopram Import Profile: Suppliers, Formulations & Sources

RISING PHARMA HOLDINGS, INC. — Escitalopram import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Escitalopram to RISING PHARMA HOLDINGS, INC.?

Verified from 194 customs shipment records

Supplier	Value	Shipments	% Share
GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$3.5M	190	98.2%
AUROBINDO PHARMA LIMITED	$63.1K	4	1.8%

RISING PHARMA HOLDINGS, INC. sources Escitalopram from 2 verified Indian suppliers based on 194 customs records. The primary supplier is GRAVITI PHARMACEUTICALS PRIVATE LIMITED accounting for 98.2% of imports.

How Does RISING PHARMA HOLDINGS, INC. Compare to Nearest Escitalopram Importers?

Buyers ranked immediately above and below #7 by import value

#	Buyer	Country	Import Value	Shipments	Avg/Shipment
4	LEK S.A.	POLAND	$4.1M	112	$36.5K
1	CIPLA MAROC	MOROCCO	$3.5M	71	$50.0K
7	RISING PHARMA HOLDINGS, INC. ★	UNITED STATES	$3.1M	174	$18.0K
3	AUROLOGISTICS LLC (AUROBINDO PHARMA	UNITED STATES	$2.9M	57	$50.0K
11	YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$2.1M	93	$22.5K

Where Does RISING PHARMA HOLDINGS, INC. Import Escitalopram To?

Destination countries from 194 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$3.5M	194	100.0%

RISING PHARMA HOLDINGS, INC. imports Escitalopram to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $3.5M.

What Escitalopram Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Formulation	Value	Shipments
ESCITALOPRAM TABLETS USP 10MG (29888X100'S) (BATCH NOS: ECB125004D)	$41.1K	1
ESCITALOPRAM TABLETS USP 10MG (29760X100'S)(BATCH NOS: ECB125005D)	$40.9K	1
ESCITALOPRAM TABLETS USP 10 MG (29504X100'S) (BATCH NOS: ECB125006D)	$40.5K	1
ESCITALOPRAM TABLETS USP 10 MG (29440X100'S) (BATCH NOS: ECB225007D)	$40.5K	1
ESCITALOPRAM TABLETS USP 10MG (29120X100'S)(BATCH NOS: ECB125009D)	$40.1K	1
ESCITALOPRAM TABLETS USP 10MG (28416X100'S)(BATCH NOS: ECB125003D)	$39.0K	1
ESCITALOPRAM TABLETS USP 10MG (3060X1000S)(BATCH NO.ECB124039G)	$35.2K	3
ESCITALOPRAM TABLETS USP 10MG (3049X1000S)(BATCH NO.ECB124040G)	$35.0K	3
ESCITALOPRAM TABLETS USP 10MG (3038X1000S)(BATCH NO.ECB124038G)	$34.9K	3
ESCITALOPRAM TABLETS USP 10MG (3034X1000'S)(BATCH NO: ECB124066G)	$34.9K	3

RISING PHARMA HOLDINGS, INC. imports 126 distinct Escitalopram formulations from India. The top formulation is ESCITALOPRAM TABLETS USP 10MG (29888X100'S) (BATCH NOS: ECB1 with 1 shipments worth $41.1K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Escitalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: RISING PHARMA HOLDINGS, INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as RISING PHARMA HOLDINGS, INC.'s capped import value divided by total capped export value for Escitalopram across all Indian exporters.
5.Verified Records: This page is backed by 194 individual customs records matching RISING PHARMA HOLDINGS, INC. importing Escitalopram, covering 126 formulations from 2 verified suppliers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 95+ countries, 628+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Escitalopram

Escitalopram

RISING PHARMA HOLDINGS, INC. — Escitalopram Importer Profile

RISING PHARMA HOLDINGS, INC. — Escitalopram Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Escitalopram to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Nearest Escitalopram Importers?

Where Does RISING PHARMA HOLDINGS, INC. Import Escitalopram To?

What Escitalopram Formulations Does RISING PHARMA HOLDINGS, INC. Import?

Regulatory Requirements: Importing Escitalopram into United States

Regulatory Authority

Approval Process for Generic Escitalopram

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Escitalopram from India and How Much Does RISING PHARMA HOLDINGS, INC. Import?

What Is the Average Order Value for RISING PHARMA HOLDINGS, INC.'s Escitalopram Imports?

Who Supplies Escitalopram to RISING PHARMA HOLDINGS, INC.?

How Does RISING PHARMA HOLDINGS, INC. Compare to Other Escitalopram Importers?

What Other CNS & Psychiatric Products Does RISING PHARMA HOLDINGS, INC. Import?

About RISING PHARMA HOLDINGS, INC.

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Escitalopram Import Data for RISING PHARMA HOLDINGS, INC.

RISING PHARMA HOLDINGS, INC. × Escitalopram

Company Overview

Top Products by RISING PHARMA HOLDINGS, INC.

Related Analysis

Need Detailed Import Data?

Data Source